An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

NCT02544750 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberous Sclerosis Complex
Seizures

Interventions

DRUG: GWP42003-P

Sponsor

Jazz Pharmaceuticals

Collaborators

[object Object]